NMDA receptor hypofunction model of schizophrenia

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904

Excitatory Amino Acid Transmitters

Watkins, J. C., & Evans, R. H. (1981) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001121 · Cited by 2,497

Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain

Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793

Glutamate receptor dysfunction and schizophrenia

Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685

Ketamine—its pharmacology and therapeutic uses

white, P. F., Way, W. L., & Trevor, A. J. (1982) · Anesthesiology · doi:10.1097/00000542-198202000-00007 · Cited by 1,474

Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs

Olney, J. W., Labruyere, J., & Price, M. T. (1989) · Science · doi:10.1126/science.2660263 · Cited by 1,230

Study of a New Schizophrenomimetic Drug—Sernyl

LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921

Adenosine A1 Receptor Agonists Block the Neuropathological Changes in Rat Retrosplenial Cortex after Administration of the NMDA Receptor Antagonist Dizocilpine

Okamura, N., Hashimoto, K., Shimizu, E., Kumakiri, C., Komatsu, N., & Iyo, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300351 · Cited by 17

Hyperresponsiveness to phencyclidine in animals lesioned in the amygdala on day 7 of life

Daenen, E. W. P. M., Wolterink, G., & van Ree, J. M. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00029-4 · Cited by 17

Aberrant regulation of NMDA receptors by dopamine D4 signaling in rats after phencyclidine exposure

Wang, X., Gu, Z., Zhong, P., Chen, G., Feng, J., & Yan, Z. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.08.018 · Cited by 16

Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: a preliminary investigation

McLean, S. L., Harte, M. K., Neill, J. C., & Young, A. M. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117704988 · Cited by 16

The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin

Reynolds, G. P. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02453-6 · Cited by 16

Ketamine-induced neurotoxicity is mediated through endoplasmic reticulum stress in vitro in STHdhQ7/Q7 cells

Rigg, N., Abu-Hijleh, F. A., Patel, V., & Mishra, R. K. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.06.004 · Cited by 17

Novel GluN2B-Selective NMDA Receptor Negative Allosteric Modulator Possesses Intrinsic Analgesic Properties and Enhances Analgesia of Morphine in a Rodent Tail Flick Pain Model

Harris, L. D., Regan, M. C., Myers, S. J., Nocilla, K. A., Akins, N. S., Tahirovic, Y. A., Wilson, L. J., Dingledine, R. J., Furukawa, H., Traynelis, S. F., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00779 · Cited by 16

The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity

Sikirić, P., Blagaić, A. B., Štrbe, S., Orešković, L. B., Orešković, I., Sikirić, S., Starešinić, M., Sever, M., Kokot, A., Jurjević, I., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17040461 · Cited by 19

Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission

Scoriels, L., Salek, R. M., Goodby, E., Grainger, D., Dean, A. M., West, J. A., Griffin, J. L., Suckling, J., Nathan, P. J., Lennox, B., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.26 · Cited by 18

Sensorimotor gating and vigilance-dependent choice accuracy: A within-subject correlative analysis in wild-type C57BL/6 mice

Bitanihirwe, B. K. Y., Dubroqua, S., Singer, P., Feldon, J., & Yee, B. K. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.10.021 · Cited by 16

Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats

Kawaura, K., Koike, H., Kinoshita, K., Kambe, D., Kaku, A., Karasawa, J.-I., Chaki, S., & Hikichi, H. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.09.046 · Cited by 16

N-methyl- d -aspartate Receptor Antagonist Ketamine Impairs Action-monitoring Activity in the Prefrontal Cortex

Skoblenick, K. J., & Everling, S. (2013) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00519 · Cited by 16

Glutamate modulators for treatment of schizophrenia

Zhand, N., Attwood, D. G., & Harvey, P. D. (2019) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2019.02.001 · Cited by 16

Two grams of sarcosine in schizophrenia – is it too much? A potential role of glutamate- serotonin interaction

Strzelecki, D., Szyburska, J., & Rabe‐Jabłońska, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s54024 · Cited by 16

Subjective Effects of Ethanol, Morphine, Δ 9 -Tetrahydrocannabinol, and Ketamine Following a Pharmacological Challenge Are Related to Functional Brain Connectivity

Kleinloog, D., Rombouts, S. A. R. B., Zoethout, R., Klumpers, L. E., Niesters, M., Khalili‐Mahani, N., Dahan, A., & van Gerven, J. (2015) · Brain Connectivity · doi:10.1089/brain.2014.0314 · Cited by 16

Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of N-Methyl- d -aspartate Receptors

Strong, K. L., Epplin, M. P., Ogden, K. K., Burger, P. B., Kaiser, T. M., Wilding, T. J., Kusumoto, H., Camp, C. R., Shaulsky, G. H., Bhattacharya, S., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00561 · Cited by 16

Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: Implications for schizophrenia

Zavitsanou, K., Nguyen, V., Newell, K. A., Ballantyne, P., & Huang, X. (2008) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2008.06.004 · Cited by 16

Aspartate in the Brain: A Review

Rae, C. D., Rowlands, B. D., & Balcar, V. J. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04454-3 · Cited by 15

Progressive Alterations in Synaptic Transmission and Plasticity of Area CA1 Precede the Cognitive Impairment Associated with Neonatal Administration of MK-801

Hernández‐Frausto, M., López‐Rubalcava, C., & Galván, E. J. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.01.036 · Cited by 15

Computational Modeling of Genetic Contributions to Excitability and Neural Coding in Layer V Pyramidal Cells: Applications to Schizophrenia Pathology

Mäki‐Marttunen, T., Devor, A., Phillips, W. A., Dale, A. M., Andreassen, O. A., & Einevoll, G. T. (2019) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2019.00066 · Cited by 14

The [18F]FDG μPET Readout of a Brain Activation Model to Evaluate the Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator JNJ-42153605

Wyckhuys, T., Wyffels, L., Langlois, X., Schmidt, M. E., Stroobants, S. G., & Staelens, S. G. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213959 · Cited by 15

Molecular identification and expression of the NMDA receptor NR1 subunit in the leech

Grey, K. B., Moss, B. L., & Burrell, B. D. (2009) · Invertebrate Neuroscience · doi:10.1007/s10158-008-0085-3 · Cited by 15

Effects of phencyclidine on auditory gating in the rat hippocampus and the medial prefrontal cortex

Dissanayake, D. W. N., Zachariou, M., Marsden, C. A., & Mason, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.032 · Cited by 15

Region-specific effects of repeated ketamine administration on the presynaptic GABAergic neurochemistry in rat brain

Boczek, T., Lisek, M., Ferenc, B., Wiktorska, M., Ivchevska, I., & Żylińska, L. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.005 · Cited by 15

A greater tendency for representation mediated learning in a ketamine mouse model of schizophrenia.

Koh, M. T., Ahrens, P. S., & Gallagher, M. (2018) · Behavioral Neuroscience · doi:10.1037/bne0000238 · Cited by 15

Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study)

Strzelecki, D., Urban‐Kowalczyk, M., & Wysokiński, A. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.002 · Cited by 15

Psychosocial Stress Induces Schizophrenia-Like Behavior in Mice With Reduced MMP-9 Activity

Vafadari, B., Mitra, S., Stefaniuk, M., & Kaczmarek, L. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00195 · Cited by 17

Changes in subunit composition of NMDA receptors in animal models of schizophrenia by repeated administration of methamphetamine

Oka, M., Ito, K., Koga, M., & Kusumi, I. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109984 · Cited by 15

Reduced activation of intracellular signaling pathways in rat prefrontal cortex after chronic phencyclidine administration

Molteni, R., PASINI, M., Moraschi, S., Gennarelli, M., Drago, F., Racagni, G., & Riva, M. A. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.02.007 · Cited by 15

Schizophrenia: more evidence for less glutamate

Morrison, P. D., & Pilowsky, L. S. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.1.29 · Cited by 15

Meeting report; “Molecular neurobiological mechanisms in schizophrenia: seeking a synthesis,” April 11–14, 1999

Goodman, A. B., & Pardee, A. B. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00904-5 · Cited by 15

Effects of subchronic clozapine treatment on long-term potentiation in rat prefrontal cortex

Gemperle, A., & Olpe, H.-R. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.10.006 · Cited by 15

Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function

Pauli, A., Prata, D. P., Mechelli, A., Picchioni, M., Fu, C. H. Y., Chaddock, C. A., Kane, F., Kalidindi, S., McDonald, C., Kravariti, E., et al. (2012) · Human Brain Mapping · doi:10.1002/hbm.22061 · Cited by 14

[18F]ALX5406: A Brain-Penetrating Prodrug for GlyT1-Specific PET Imaging

Hoffmann, C., Evcüman, S., Neumaier, F., Zlatopolskiy, B. D., Humpert, S., Bier, D. D., Holschbach, M. H., Schulze, A., Endepols, H., & Neumaier, B. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00284 · Cited by 14

Close to the edge: co-authorship proximity of Nobel laureates in Physiology or Medicine, 1991–2010, to cross-disciplinary brokers

Fields, C. (2015) · Scientometrics · doi:10.1007/s11192-015-1526-5 · Cited by 13

Postnatal neurodevelopmental expression and glutamate-dependent regulation of the ZNF804A rodent homologue

Chang, E. H., Kirtley, A., Chandon, T.-S. S., Borger, P., Husain-Krautter, S., Vingtdeux, V., & Malhotra, A. K. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.023 · Cited by 14

Triazolopyridine ethers as potent, orally active mGlu2 positive allosteric modulators for treating schizophrenia

Higgins, M. A., Marcin, L. R., Zusi, F. C., Gentles, R. G., Ding, M., Pearce, B. C., Easton, A. E., Kostich, W. A., Seager, M. A., Bourin, C., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.018 · Cited by 14

Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method

Randau, M., Oranje, B., Miyakoshi, M., Makeig, S., Fagerlund, B., Glenthoj, B. Y., & Bak, N. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101760 · Cited by 14

Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine loss

Moy, S. S., Fernandes, A., Ying, Q., Rotella, D. J., Kostrewa, R. M., & Breese, G. R. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.02.013 · Cited by 14

3α5β-Pregnanolone glutamate, a use-dependent NMDA antagonist, reversed spatial learning deficit in an animal model of schizophrenia.

Valeš, K., Rambousek, L., Holubová, K., Svoboda, J., Bubeníková-Valešová, V., Chodounská, H., Vyklický, L., & Stuchlík, A. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.020 · Cited by 15

Glycine-induced long-term synaptic potentiation is mediated by the glycine transporter GLYT1

Igartua, I., Solís, J. M., & Bustamante, J. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.03.003 · Cited by 14

Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors

Balsara, R. D., Li, N. Y., Weber‐Adrian, D., Huang, L., & Castellino, F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.018 · Cited by 15

Different serine and glycine metabolism in patients with schizophrenia receiving clozapine

Hons, J., Vašatová, M., Čermáková, E., Doubek, P., & Libiger, J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.015 · Cited by 14

Expression of the NR3A Subunit of the NMDA Receptor in Human Fetal Brain

Mueller, H. T., & Meador‐Woodruff, J. H. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.049 · Cited by 14

The association between peripheral inflammation, brain glutamate and antipsychotic response in Schizophrenia: Data from the STRATA collaboration

Fenn‐Moltu, S., Deakin, J. F. W., Drake, R., Howes, O. D., Lawrie, S. M., Lewis, S. W., Nikkheslat, N., Walters, J., MacCabe, J. H., Mondelli, V., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.05.005 · Cited by 13

Therapeutic potential of D-amino acid oxidase inhibitors for cognitive impairment associated with schizophrenia: learnings from luvadaxistat

Terry-Lorenzo, R. T., Fan, R. H., Khin, N. A., & Singh, J. B. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae066 · Cited by 14

Deletion of the Mitochondrial Matrix Protein CyclophilinD Prevents Parvalbumin Interneuron Dysfunctionand Cognitive Deficits in a Mouse Model of NMDA Hypofunction

Phensy, A. J., Lindquist, K. L., Lindquist, K. A., Bairuty, D., Gauba, E., Guo, L., Tian, J., Du, H., & Kroener, S. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0880-20.2020 · Cited by 13

Translational psychiatry—light at the end of the tunnel

Jones, K., Menniti, F. S., & Sivarao, D. V. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12725 · Cited by 13

Chronic nicotine attenuates phencyclidine-induced impulsivity in a mouse serial reaction time task

Scott, D., & Taylor, J. R. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.009 · Cited by 13

Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors

Thomson, J. L., Blackaby, W., Jennings, A. S. R., Goodacre, S. C., Pike, A. J., Thomas, S., Brown, T. A., Smith, A. J., Pillai, G. V., Street, L. J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.102 · Cited by 13

Involvement of AMPA/kainate-excitotoxicity in MK801-induced neuronal death in the retrosplenial cortex

Bender, C. L., Rassetto, M., de Olmos, J. S., de Olmos, S., & Lorenzo, A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.007 · Cited by 13

The influence of dopaminergic system in medial prefrontal cortex on ketamine-induced amnesia in passive avoidance task in mice

Farahmandfar, M., Bakhtazad, A., Akbarabadi, A., & Zarrindast, M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.060 · Cited by 14

BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study)

Strzelecki, D., Kałużyńska, O., & Wysokiński, A. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.019 · Cited by 13

Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study

Borgan, F., Veronese, M., Marques, T. R., Lythgoe, D. J., & Howes, O. D. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01191-2 · Cited by 13

Pre-clinical models of cognitive dysfunction in schizophrenia: new avenues to addressing unmet needs

Jentsch, J. D. (2003) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2003.10.011 · Cited by 13

Neurobiology of glutamatergic abnormalities in schizophrenia

Haroutunian, V. H., Dracheva, S. M., & Davis, K. L. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00020-3 · Cited by 13

Discovery and SAR studies of novel GlyT1 inhibitors

Walter, M. W., Hoffman, B. J., Gordon, K. D., Johnson, K. W., Love, P. L., Jones, M., Man, T., Phebus, L. A., Reel, J. K., Rudyk, H., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.06.074 · Cited by 13

Adjunctive Memantine for Catatonia Due to Anti-NMDA Receptor Encephalitis

Kim, K., Caravella, R. A., Deutch, A. B., & Gurin, L. J. (2023) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20220206 · Cited by 12

Etomidate and Ketamine: Residual Motor and Adrenal Dysfunction that Persist beyond Recovery from Loss of Righting Reflex in Rats

Diaz‐Gil, D., Mueller, N., Moreno‐Duarte, I., Lin, H. H., Ayata, C., Cusin, C., Cotten, J. F., & Eikermann, M. (2014) · Pharmaceuticals · doi:10.3390/ph8010021 · Cited by 13

Psychotomimetic effects of different doses of MK-801 and the underlying mechanisms in a selective memory impairment model

Liu, W., Wang, D., Hong, W., Yu, Y., Tang, J., Wang, J., Liu, F., Xu, X., Tan, L., & Chen, X. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.011 · Cited by 12

Negative modulation of α 5 GABA A receptors in rats may partially prevent memory impairment induced by MK-801, but not amphetamine- or MK-801-elicited hyperlocomotion

Stamenić, T. T., Joksimovic, S. M., Biawat, P., Stanković, T., Marković, B. D., Cook, J. M., & Savić, M. M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115590601 · Cited by 12

MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study)

Strzelecki, D., Kałużyńska, O., Szyburska, J., & Wysokiński, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071075 · Cited by 12

Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study)

Strzelecki, D., Urban‐Kowalczyk, M., & Wysokiński, A. (2018) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2652 · Cited by 12

Quantum energy levels of glutamate modulate neural biophotonic signals

Han, Z., Chai, W., Wang, Z., Xiao, F., & Dai, J. (2021) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-021-00022-0 · Cited by 12

Fission and Fusion of the Neuronal Endoplasmic Reticulum

Kucharz, K., Wieloch, T. W., & Toresson, H. (2013) · Translational Stroke Research · doi:10.1007/s12975-013-0279-9 · Cited by 12

New Vistas in the Management of Treatment-Refractory Psychiatric Disorders: Genomics and Personalized Medicine

Myers, A., & Nemeroff, C. B. (2010) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.8.4.foc525 · Cited by 12

Prepulse inhibition is different in two inbred mouse strains (CPB-K and BALB/cJ) with different hippocampal NMDA receptor densities

Wolf, R. J., Dobrowolny, H., Matzke, K., Paelchen, K., Bogerts, B., & Schwegler, H. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.07.027 · Cited by 12

No blind schizophrenics: Are NMDA-receptor dynamics involved?

Sanders, G. S., Platek, S. M., & Gallup, G. G. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03420025 · Cited by 13

Glutamatergic Approaches to the Conceptualization and Treatment of Schizophrenia

Kantrowitz, J. T., & Javitt, D. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_3 · Cited by 12

Toward an Explanation of the Genesis of Ketamine-Induced Perceptual Distortions and Hallucinatory States

Pereira, A., & Johnson, G. (2003) · Brain and Mind · doi:10.1023/b:bram.0000005466.28582.27 · Cited by 12

A selective review of inhibitors of protein kinase C gamma: a neuroplasticity-related common pathway for psychiatric illness

Grados, M. A., Salehi, M., Lotfi, A., Dua, S. S., & Xie, I. Y. (2024) · Frontiers in Drug Delivery · doi:10.3389/fddev.2024.1364037 · Cited by 14

Quantification of the glycine transporter 1 in rhesus monkey brain using [18F]MK-6577 and a model-based input function

Bohorquez, S. M. S., Joshi, A. D., Holahan, M. A., Daneker, L., Riffel, K. A., Williams, M., Li, W., Cook, J. J., & Hamill, T. G. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.080 · Cited by 11

Functional effects of disease-associated variants reveal that the S1–M1 linker of the NMDA receptor critically controls channel opening

Xie, L., McDaniel, M. J., Perszyk, R. E., Kim, S., Cappuccio, G., Shapiro, K. A., Cabello, B. M., Sanchez-Lara, P. A., Grand, K., Zhang, J., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04705-y · Cited by 10

Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia

Griffiths, K., Smart, S. E., Barker, G. J., Deakin, J. F. W., Lawrie, S. M., Lewis, S. W., Lythgoe, D. J., Pardiñas, A. F., Singh, K. D., Semple, S., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.08.020 · Cited by 11

Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analyses

Adams, W. K., Halberstadt, A. L., & van den Buuse, M. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00109 · Cited by 10

Involvement of the Striatal Medium Spiny Neurons of the Direct Pathway in the Motor Stimulant Effects of Phencyclidine

Bonito-Oliva, A., DuPont, C. M., Madjid, N., Ögren, S. O., & Fisone, G. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv134 · Cited by 11

Role of the cytokine network in major psychoses

Müller, N., & Schwarz, M. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31045-8 · Cited by 11

l-Stepholidine increases the frequency of sEPSC via the activation of D1dopamine signaling pathway in rat prelimbic cortical neurons

Gao, M., Liu, C., Shen, Y. A. N. G., Xue-chu, Z. H. E. N., & Jin, G.-Z. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00547.x · Cited by 12

Cellular, synaptic, and circuit effects of antibodies in autoimmune CNS synaptopathies

Jain, A., & Balice‐Gordon, R. J. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00005-0 · Cited by 11

The neurochemistry of schizophrenia

Reynolds, G. P. (2008) · Psychiatry · doi:10.1016/j.mppsy.2008.07.014 · Cited by 10

Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia

Adams, W. K., Ayton, S., & van den Buuse, M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1617-1 · Cited by 10

Molecular and Cellular Mechanisms Associated with Autoimmune Diseases

Ayensu, W. K., Tchounwou, P. B., & McMurray, R. W. (2004) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph2004010039 · Cited by 9

Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: Development of a potent and CNS penetrant [3.1.0]-based lead

Jones, C. K., Sheffler, D. J., Williams, R. D., Jadhav, S. B., Felts, A. S., Morrison, R. D., Niswender, C. M., Daniels, J. S., Conn, P. J., & Lindsley, C. W. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.01.013 · Cited by 10

Age-dependent effects of (+)-MK801 treatment on glutamate release and metabolism in the rat medial prefrontal cortex

Zou, Y., Zhang, H., Chen, X., Ji, W., Mao, L., & Lei, H. C. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104503 · Cited by 10

Similar destabilization of neural dynamics under different general anesthetics

Eisen, A. J., Bardon, A. G., Ballesteros, J. J., Bastos, A. M., Donoghue, J., Mahnke, M. K., Brincat, S. L., Roy, J. E., Ishizawa, Y., Brown, E. N., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117048 · Cited by 8

Pharmacological treatment of schizophrenia - a review of progress

Dimitrelis, K., & Shankar, R. (2016) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.430 · Cited by 9

Polygenic Risk for Schizophrenia, Major Depression, and Post-traumatic Stress Disorder and Hippocampal Subregion Volumes in Middle Childhood

Pine, J. G., Paul, S. E., Johnson, E. C., Bogdan, R., Kandala, S., & Barch, D. M. (2023) · Behavior Genetics · doi:10.1007/s10519-023-10134-1 · Cited by 9

Psychiatric features in NMDAR and LGI1 antibody–associated autoimmune encephalitis

Jia, Y., Li, M., Hu, S., Leng, H., Yang, X., Xue, Q., Zhang, M., Wang, H., Huang, Z., Wang, H., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01606-w · Cited by 9

Ketamine modulates the exploratory dynamics and homebase-related behaviors of adult zebrafish

Pretzel, C. W., Borba, J. V., Resmim, C. M., de Abreu, M. S., Kalueff, A. V., Fontana, B. D., Canzian, J., & Rosemberg, D. B. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173892 · Cited by 9

A Neural Mass Model for Abnormal Beta-Rebound in Schizophrenia

Byrne, Á., Coombes, S., & Liddle, P. F. (2019) · Springer series in cognitive and neural systems · doi:10.1007/978-3-030-18830-6_3 · Cited by 11

Using iPSC Models to Understand the Role of Estrogen in Neuron–Glia Interactions in Schizophrenia and Bipolar Disorder

de Assis, D. R., Szabó, A., Osete, J. R., Puppo, F., O’Connell, K. S., Akkouh, I. A., Hughes, T., Frei, E., Andreassen, O. A., & Djurovic, S. (2021) · Cells · doi:10.3390/cells10020209 · Cited by 10

The expression of genes involved in glucose metabolism is affected by N‐methyl‐D‐aspartate receptor antagonism: A putative link between metabolism and an animal model of psychosis

Iasevoli, F., Latte, G., Avvisati, L., Sarappa, C., Aloj, L., & de Bartolomeis, A. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23071 · Cited by 8

Mechanisms of disrupted language comprehension in schizophrenia

Condray, R., & Steinhauer, S. R. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03270023 · Cited by 9

Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density

Wolf, R. J., Paelchen, K., Matzke, K., Dobrowolny, H., Bogerts, B., & Schwegler, H. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0824-x · Cited by 9

Windows to the Brain: Insights From Neuroimaging

Taber, K. H. (2008) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615377886 · Cited by 9

Anatomic Brain Imaging Studies of Normal and Abnormal Brain Development in Children and Adolescents

Giedd, J. N., Shaw, P., Wallace, G. L., Gogtay, N., & Lenroot, R. (2015) · Wiley eBooks · doi:10.1002/9780470939390.ch3 · Cited by 9

Brain Neuroplasticity Mechanisms in Psychiatric Illnesses and in the Development of Novel Treatments

O’Donnell, P., Etkin, A., & Manji, H. K. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20251212 · Cited by 8

6-Hydroxydopamine Lesioning of Dopamine Neurons in Neonatal and Adult Rats Induces Age-Dependent Consequences

Papadeas, S. T., & Breese, G. R. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_59 · Cited by 8

MGlur5 Positive Allosteric Modulation Prevents MK-801 Induced Increases in Extracellular Glutamate in the Rat Medial Prefrontal Cortex

LaCrosse, A., May, C. E., Griffin, W. C., & Olive, M. F. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.06.016 · Cited by 8

Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processing

Klamer, D., Svensson, L., Fejgin, K., & Pålsson, E. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.10.010 · Cited by 8

Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia

Lindsley, C. W., Shipe, W. D., Wolkenberg, S. E., Theberge, C. R., Williams, D., Jr., Sur, C., & Kinney, G. G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777057599 · Cited by 156

The Hypothesis of NMDA Receptor Hypofunction for Schizophrenia

Chang, H.-J., Lane, H., & Tsai, G. E. (2012) · 臺灣精神醫學 · doi:10.29478/tjp.201209.0003

The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

Jentsch, J. D. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,329

Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies

Marino, M. J., & Conn, P. J. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339544 · Cited by 134

N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Could Arise From Reduced Cortical Connectivity Rather Than Receptor Dysfunction

Hoffman, R. E. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180096017 · Cited by 3